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Biology

Recurrence Risk for Women with Abnormal
First and Second Trimester Serum
Screening Markers in a Subsequent Pregnancy
and Risks of Adverse Outcomes in Women with
Low Pregnancy-Associated Plasma Protein-A
(PAPP-A) and a Normally Growing Fetus
Casey Brooks
Mentors: Joanne Stone, Angela Bianco, and Chloe Getrajdman
Routine prenatal first and second trimester serum markers are measured in pregnant
women for aneuploidy screening. Literature supports an association between abnormal
markers and adverse pregnancy outcomes relating to placental dysfunction and fetal
growth disorders. However, there is paucity of information on whether a woman with
abnormal markers in one pregnancy is at risk for abnormal markers in a subsequent
pregnancy as well as the risk of adverse pregnancy outcomes in women with low PAPP-A,
a risk factor for fetal growth restriction, and a normally growing fetus (AGA). We
present two analyses: (1) the risk of recurrent abnormal serum markers in consecutive
pregnancies; (2) the risk of adverse outcomes for a woman with low PAPP-A and AGA
fetus. Patients for both analyses were identified from a database, with data available for
markers in consecutive pregnancies in (1) and maternal characteristics/delivery for (2).
We performed a retrospective cohort analysis via chart review and used student’s t-test,
chi-square, or Fisher’s exact test where appropriate. For each marker analyzed, there
was an increased risk of having an abnormal marker in a subsequent pregnancy after
having that marker in the first. In measuring cross-markers, we found no increased risk.
In comparing low PAPP-A cases with normal PAPP-A controls, we found an increased
risk of cesarean section for the cases with no trend regarding non-reassuring fetal
heart rate. Further studies are necessary to investigate potential underlying maternal
pathophysiology leading to abnormal serum markers and if fetal testing or planned
delivery for low PAPP-A cases is indicated.
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